Table 2.
Univariable Analysis of Factors Associated With MAFLD
| Variables | Odds ratios (95% CI) | P |
|---|---|---|
| Weight at MPC visit | 1.07 (1.05–1.09) | <.001 |
| Weight on admission | 1.05 (1.03–1.08) | <.001 |
| Weight at hospital discharge | 1.05 (1.03–1.08) | <.001 |
| BMI at MPC visit | 1.22 (1.14–1.32) | <.001 |
| BMI on hospital admission | 1.11 (1.06–1.17) | <.001 |
| BMI at hospital discharge | 1.10 (1.05–1.15) | <.001 |
| Waist circumference | 1.07 (1.04–1.10) | <.001 |
| Total cholesterol | 1.01 (1.0–1.01) | .054 |
| LDL cholesterol | 1.01 (1.0–1.01) | .051 |
| Total cholesterol to HDL cholesterol ratio | 1.37 (1.05–1.80) | .02 |
| Triglycerides | 1.01 (1.0–1.02) | <.001 |
| HOMA | 1.98 (1.53–2.55) | <.001 |
| Obesity | 4.67 (2.59–8.41) | <.001 |
| Diabetes mellitus | 3.5 (1.45–8.43) | .005 |
| Metabolic syndrome | 4.19 (2.13–8.23) | <.001 |
| Systolic blood pressure | 1.02 (1.0–1.03) | .08 |
| Diastolic blood pressure | 1.05 (1.02–1.09) | .002 |
| Use of glucocorticoids | 1.64 (0.95–2.84) | .08 |
| Use of statins at MPC visit | 1.88 (0.95–3.71) | .07 |
| Number of reported PACS symptoms | 0.9 (0.82–0.99) | .03 |
| Neurocognitive PACS | 0.57 (0.33–0.98) | .04 |
| Psychological PACS | 0.51 (0.29–0.9) | .02 |
Abbreviations: BMI, body mass index; CI, confidence interval; HDL, high-density lipoprotein; HOMA, homeostatic model assessment for insulin resistance; LDL, low-density lipoprotein; MAFLD, metabolic-associated fatty liver disease; MPC, Modena PACS Clinic; PACS, postacute COVID-19 syndrome.